Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

FDA approved bronchodilator carmoterol and d-methamphetamine found in 23 drug tests from horses running at Lone Star Park ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January ...

(MENAFN- ACN NewsWire) China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal ... eosinophilic esophagitis, chronic obstructive pulmonary disease and so on.

Authenticated data presented in the Respiratory Drugs market report is based on findings of extensive primary and secondary research ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

these 5 treatments may be options to help restore your breathing during a COPD flare-up. This type of medication requires a prescription from your doctor. They may also suggest a long-acting ...